First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors

por Mross, Klaus, Richly, Heike, Fischer, Richard, Scharr, Dirk, Büchert, Martin, Stern, Angelika, Gille, Hendrik, Audoly, Laurent P., Scheulen, Max E.
Publicado 2013

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

por Wildner, Dane, Heinzerling, Lucie, Scheulen, Max E., Kaempgen, Eckhart, Schuler, Gerold, Strobel, Deike, Janka, Rolf, Neurath, Markus F., Sturm, Joerg, Knieling, Ferdinand
Publicado 2021

A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors

por Mross, Klaus, Richly, Heike, Frost, Annette, Scharr, Dirk, Nokay, Bahar, Graeser, Ralph, Lee, Chooi, Hilbert, James, Goeldner, Rainer-George, Fietz, Oliver, Scheulen, Max E.
Publicado 2016

Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer

por Mross, Klaus, Frost, Annette, Scheulen, Max E, Krauss, Jürgen, Strumberg, Dirk, Schultheiss, Beate, Fasol, Ulrike, Büchert, Martin, Krätzschmer, Jörn, Delesen, Heinz, Rajagopalan, Prabhu, Christensen, Olaf
Publicado 2011

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors

por Plummer, Ruth, Madi, Ayman, Jeffels, Melinda, Richly, Heike, Nokay, Bahar, Rubin, Stephen, Ball, Howard A., Weller, Steve, Botbyl, Jeffrey, Gibson, Diana M., Scheulen, Max E.
Publicado 2012

Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center

por Welt, Anja, Bogner, Simon, Arendt, Marina, Kossow, Josef, Huffziger, Antonia, Pohlkamp, Christian, Steiniger, Heike, Becker, Ute, Alashkar, Ferras, Kohl, Marzena, Wiesweg, Marcel, Richly, Heike, Hense, Jörg, Scheulen, Max E., Schuler, Martin, Seeber, Siegfried, Tewes, Mitra
Publicado 2020